Vera Therapeutics, Inc. - Class A Common Stock, par value $0.001 per share (VERA)

Q: What does CUSIP 92337R101 represent in this 13F holders report?

CUSIP 92337R101 is the security identifier for VERA - Vera Therapeutics, Inc. - Class A Common Stock, par value $0.001 per share used to aggregate holder disclosures.

Q: How many institutions held VERA - Vera Therapeutics, Inc. - Class A Common Stock, par value $0.001 per share in Q1 2022?

49 institutional investors reported VERA - Vera Therapeutics, Inc. - Class A Common Stock, par value $0.001 per share for Q1 2022. Use the holders table for investor-level position and value details.

CUSIP: 92337R101

Q1 2022 13F Holders as of 31 Mar 2022

Type / Class: Equity / Class A Common Stock, par value $0.001 per share
Shares outstanding: 72,325,000
Total 13F shares: 19,483,745
Share change: +5,548,112
Total reported value: $457,319,068
Price per share: $23.49
Number of holders: 49
Value change: +$130,146,246
Number of buys: 36
Number of sells: 10

Quarterly Holders Quick Answers

What is CUSIP 92337R101?
CUSIP 92337R101 identifies VERA - Vera Therapeutics, Inc. - Class A Common Stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q2 2022
Previous quarter: Q4 2021

Recent filing periods for CUSIP 92337R101:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of VERA - Vera Therapeutics, Inc. - Class A Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
FMR LLC	13F	Company	4.3%	3,145,202	$84,040,000	—	31 Dec 2021	13F
Abingworth LLP	13F 3/4/5	Company · 10%+ Owner	4.1%	2,960,231	$78,535,000	—	31 Dec 2021	13F 3/4/5
Sofinnova Investments, Inc.	13F	Company	4%	2,914,776	$77,883,000	—	31 Dec 2021	13F
Emster Kurt von	3/4/5	Director	— mixed-class rows	2,987,984 mixed-class rows	$53,605,062	—	17 May 2021	3/4/5
CITADEL ADVISORS LLC	13F	Company	2.4%	1,733,182	$46,311,000	—	31 Dec 2021	13F
Alphabet Inc.	13F	Company	0.99%	713,658	$19,069,000	—	31 Dec 2021	13F
Octagon Capital Advisors LP	13F	Company	0.93%	670,940	$17,928,000	—	31 Dec 2021	13F
BlackRock Finance, Inc.	13F	Company	0.63%	455,100	$12,161,000	—	31 Dec 2021	13F
VANGUARD GROUP INC	13F	Company	0.54%	388,978	$10,394,000	—	31 Dec 2021	13F
Kynam Capital Management, LP	13F	Company	0.35%	253,449	$6,772,000	—	31 Dec 2021	13F
STATE STREET CORP	13F	Company	0.17%	123,273	$3,294,000	—	31 Dec 2021	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.17%	121,582	$3,248,000	—	31 Dec 2021	13F
INTERNATIONAL BIOTECHNOLOGY TRUST PLC	13F	Company	0.17%	120,535	$3,198,000	—	31 Dec 2021	13F
NORTHERN TRUST CORP	13F	Company	0.11%	77,853	$2,080,000	—	31 Dec 2021	13F
JPMORGAN CHASE & CO	13F	Company	0.11%	76,126	$2,035,000	—	31 Dec 2021	13F
Logos Global Management LP	13F	Company	0.07%	50,000	$1,336,000	—	31 Dec 2021	13F
CARNEGIE MELLON UNIVERSITY	13F	Company	0.04%	32,120	$858,000	—	31 Dec 2021	13F
MORGAN STANLEY	13F	Company	0.04%	26,687	$714,000	—	31 Dec 2021	13F
Gyon Technologies Capital Management, LP	13F	Company	0.03%	24,553	$656,000	—	31 Dec 2021	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.03%	23,492	$628,000	—	31 Dec 2021	13F
Parkman Healthcare Partners LLC	13F	Company	0.03%	21,555	$576,000	—	31 Dec 2021	13F
Bank of New York Mellon Corp	13F	Company	0.03%	20,589	$550,000	—	31 Dec 2021	13F
Raymond James Financial Services Advisors, Inc.	13F	Company	0.02%	17,828	$476,000	—	31 Dec 2021	13F
Nuveen Asset Management, LLC	13F	Company	0.02%	15,098	$344,000	—	31 Dec 2021	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.02%	11,907	$318,000	—	31 Dec 2021	13F
CAMBRIDGE TRUST CO	13F	Company	0.01%	9,887	$264,000	—	31 Dec 2021	13F
JANE STREET GROUP, LLC	13F	Company	0.01%	8,287	$221,000	—	31 Dec 2021	13F
NEW YORK STATE COMMON RETIREMENT FUND	13F	Company	0.01%	6,549	$175,000	—	31 Dec 2021	13F
DEUTSCHE BANK AG\	13F	Company	0.01%	6,013	$161,000	—	31 Dec 2021	13F
WELLS FARGO & COMPANY/MN	13F	Company	0.01%	5,697	$152,000	—	31 Dec 2021	13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	13F	Company	0.01%	5,416	$145,000	—	31 Dec 2021	13F
AMERICAN INTERNATIONAL GROUP, INC.	13F	Company	0.01%	5,259	$141,000	—	31 Dec 2021	13F
ROYAL BANK OF CANADA	13F	Company	0%	2,696	$72,000	—	31 Dec 2021	13F
CITIGROUP INC	13F	Company	0%	2,657	$71,000	—	31 Dec 2021	13F
STRS OHIO	13F	Company	0%	1,600	$42,000	—	31 Dec 2021	13F
Legal & General Group Plc	13F	Company	0%	933	$25,000	—	31 Dec 2021	13F
Ameritas Investment Partners, Inc.	13F	Company	0%	542	$14,000	—	31 Dec 2021	13F
Tower Research Capital LLC (TRC)	13F	Company	0%	538	$14,000	—	31 Dec 2021	13F

Institutional Holders of Vera Therapeutics, Inc. - Class A Common Stock, par value $0.001 per share (VERA) as of Q1 2022

As of 31 Mar 2022, Vera Therapeutics, Inc. - Class A Common Stock, par value $0.001 per share (VERA) was held by 49 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 19,483,745 shares. The largest 10 holders included FMR LLC, Sofinnova Investments, Inc., Abingworth LLP, CITADEL ADVISORS LLC, RA CAPITAL MANAGEMENT, L.P., BlackRock Inc., Vivo Capital, LLC, VANGUARD GROUP INC, Octagon Capital Advisors LP, and Kynam Capital Management, LP. This page lists 49 institutional shareholders reporting positions in this security for the Q1 2022 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q1 2022 vs Q4 2021 Across Filers

Q4 2021 holders

Q1 2022 holders

Holder diff

Investor	Q4 2021 Shares	Q1 2022 Shares	Share Diff	Share Chg %	Q4 2021 Value $	Q1 2022 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.